Bioequivalence Study of Dr.Reddy's Fexofenadine Hydrochloride 180 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2002-05-01
Target enrollment:
Participant gender:
Summary
Randomized, 2-Way Crossover, Bioequivalence Study of Fexofenadine Hydrochloride 180 mg
Tablets of Dr.Reddy's Laboratories Limited, and Allegra® 180 mg Tablets, Aventis Administered
as 1 x 180 mg Tablet in Healthy Subjects under Fasting Conditions